- Dusek Ladislav, Muzik Jan, Kubasek Miroslav, Koptikova Jana, Zaloudik Jan, Vyzula Rostislav. Epidemiology of Malignant Tumours in the Czech Republic [online]. Masaryk University, Czech Republic, [2005], [cit. 2019-12-03]. http://www.svod.cz. Version 7.0 [2007], ISSN 1802 – 8861.
- Svoboda M, Navrátil J, Fabian P, Palácová M, Gombošová J, Slámová L et al.Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009. Klin Onkol. 2012;25(3):188-98.
- Zhi H, Ou B, Luo B-M, Feng X, Wen Y-L, Yang H-Y. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. J Ultrasound Med.2007;26(6):807–15.
- Wang Z, Tang J, An L, Wang W, Luo Y, Li J, et al. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med.2007;26(6):757–62.
- Jia W-R, Chai W-M, Tang L, Wang Y, Fei X-C, Han B-S, et al. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors. Eur J Radiol.2014;83(7):1098–105.
- Quan J, Hong Y, Zhang X, Mei M, You X, Huang P. The clinical role of contrast enhanced ultrasound in differential diagnosis of BI-RADS 4 breast disease. Clin Hemorheol Microcirc. 2019;72(3):293-303.
- Lee SC, Tchelepi H, Grant E, Desai B, Luo C, Groshen S, Hovanessian-Larsen L. Contrast-Enhanced Ultrasound Imaging of Breast Masses: Adjunct Tool to Decrease the Number of False-Positive Biopsy Results. J Ultrasound Med. 2019;38(9):2259-2273.
- Tang L, Chen Y, Du Z, Zhong Z, Chen Q, Yang L, et al. A multicenter study of a contrast-enhanced ultrasound diagnostic classification of breast lesions. Cancer Manag Res. 2019; 11: 2163–2170.
Carmeliet P. Angiogenesis in life, disease and medicine. Nature.2005;438(7070):932–6.
Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med.1971;285(21):1182–6.
Szabó BK, Saracco A, Tánczos E, Aspelin P, Leifland K, Wilczek B, et al. Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer. Eur Radiol. 2013;23(12):3228-36. doi: 10.1007/s00330-013-2960-5. Epub 2013 Jul 3.
Zhou YH, Tan F, Hess KR, Yung WKA. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: Relationship to tumor grade and survival.Clin Cancer Res. 2003 Aug 15;9(9):3369-75.
Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, et al. Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis. Clin Cancer Res.2005;11(10):3647–53.
Linderholm B, Lindh B, Beckman L, Erlanson M, Edin K, Travelin B, et al. Prognostic Correlation of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in 1307 Primary Breast Cancers. Clin Breast Cancer. 2003;4(5):340-7.
Ricci P, Cantisani V, Ballesio L, Pagliara E, Sallusti E, Drudi F, et al. Benign and Malignant Breast Lesions: Efficacy of Real Time Contrast-Enhanced Ultrasound vs. Magnetic Resonance Imaging. Ultraschall Med. 2007;28(1):57-62.
Cao X-L, Bao W, Zhu S-G, Wang L-H, Sun M-H, Wang L, et al. Contrast-enhanced ultrasound characteristics of breast cancer: correlation with prognostic factors. Ultrasound Med Biol.2014;40(1):11–7. doi: 10.1016/j.ultrasmedbio.2013.08.014. Epub 2013 Oct 24.
Du J, Li F-H, Fang H, Xia J-G, Zhu C-X. Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions. J Ultrasound Med.2008;27(6):821–31.
Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions. Eur J Radiol. 2010;73(2):288-93. doi: 10.1016/j.ejrad.2009.05.043. Epub 2009 Jun 25.
Wan C, Du J, Fang H, Li F, Wang L. Evaluation of breast lesions by contrast enhanced ultrasound: Qualitative and quantitative analysis. Eur J Radiol. 2012;81(4):e444-50. doi: 10.1016/j.ejrad.2011.03.094. Epub 2011 May 25.
Du J, Wang L, Wan C-F, Hua J, Fang H, Chen J, et al. Differentiating benign from malignant solid breast lesions: Combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. Eur J Radiol. 2012;81(12):3890-9. doi: 10.1016/j.ejrad.2012.09.004. Epub 2012 Oct 11.
Chen Y, Tang L, Du Z, Zhong Z, Luo J, Yang L, et al. Factors influencing the performance of a diagnostic model including contrast-enhanced ultrasound in 1023 breast lesions: comparison with histopathology. Ann Transl Med. 2019; 7(22): 647.
Kapetas P, Clauser P, Woitek R, Wengert GJ, Lazar M, Pinker K, et al. Quantitative multiparametric breast ultrasound: application of contrastenhanced ultrasound and elastography leads to an improved differentiation of benign and malignant lesions. Invest Radiol. 2019;54(5):257-264.
Kamei K, Kaneoka Y, Harada T, Maeda A, Imayoshi Y, Yoshida M, et al. Investigation of contrast-enhanced ultrasound findings for the differential diagnosis of small breast lesions. Ultrasound Med Biol. 2019; 45:S43
Shao SH, Li ChX, Yao MH, Li G, Li X, Wu R. Incorporation of contrast-enhanced ultrasound in the differential diagnosis for breast lesions with inconsistent results on mammography and conventional ultrasound. Clin Hemorheol Microcirc. 2020. DOI 10.3233/CH-190729
loudik Jan, Vyzula Rostislav. Epidemiology of Malignant Tumours in the Czech Republic [online]. Masaryk University, Czech Republic, [2005], [cit. 2019-12-03]. http://www.svod.cz. Version 7.0 [2007], ISSN 1802 – 8861.
Svoboda M, Navrátil J, Fabian P, Palácová M, Gombošová J, Slámová L et al.Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009. Klin Onkol. 2012;25(3):188-98.
Zhi H, Ou B, Luo B-M, Feng X, Wen Y-L, Yang H-Y. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. J Ultrasound Med.2007;26(6):807–15.
Wang Z, Tang J, An L, Wang W, Luo Y, Li J, et al. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med.2007;26(6):757–62.
Jia W-R, Chai W-M, Tang L, Wang Y, Fei X-C, Han B-S, et al. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors. Eur J Radiol.2014;83(7):1098–105.
Carmeliet P. Angiogenesis in life, disease and medicine. Nature.2005;438(7070):932–6.
Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med.1971;285(21):1182–6.
Szabó BK, Saracco A, Tánczos E, Aspelin P, Leifland K, Wilczek B, et al. Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer. Eur Radiol. 2013;23(12):3228-36. doi: 10.1007/s00330-013-2960-5. Epub 2013 Jul 3.
Zhou YH, Tan F, Hess KR, Yung WKA. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: Relationship to tumor grade and survival.Clin Cancer Res. 2003 Aug 15;9(9):3369-75.
Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, et al. Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis. Clin Cancer Res.2005;11(10):3647–53.
Linderholm B, Lindh B, Beckman L, Erlanson M, Edin K, Travelin B, et al. Prognostic Correlation of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in 1307 Primary Breast Cancers. Clin Breast Cancer. 2003;4(5):340-7.
Ricci P, Cantisani V, Ballesio L, Pagliara E, Sallusti E, Drudi F, et al. Benign and Malignant Breast Lesions: Efficacy of Real Time Contrast-Enhanced Ultrasound vs. Magnetic Resonance Imaging. Ultraschall Med. 2007;28(1):57-62.
Cao X-L, Bao W, Zhu S-G, Wang L-H, Sun M-H, Wang L, et al. Contrast-enhanced ultrasound characteristics of breast cancer: correlation with prognostic factors. Ultrasound Med Biol.2014;40(1):11–7. doi: 10.1016/j.ultrasmedbio.2013.08.014. Epub 2013 Oct 24.
Du J, Li F-H, Fang H, Xia J-G, Zhu C-X. Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions. J Ultrasound Med.2008;27(6):821–31.
Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions. Eur J Radiol. 2010;73(2):288-93. doi: 10.1016/j.ejrad.2009.05.043. Epub 2009 Jun 25.
Wan C, Du J, Fang H, Li F, Wang L. Evaluation of breast lesions by contrast enhanced ultrasound: Qualitative and quantitative analysis. Eur J Radiol. 2012;81(4):e444-50. doi: 10.1016/j.ejrad.2011.03.094. Epub 2011 May 25.
Du J, Wang L, Wan C-F, Hua J, Fang H, Chen J, et al. Differentiating benign from malignant solid breast lesions: Combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. Eur J Radiol. 2012;81(12):3890-9. doi: 10.1016/j.ejrad.2012.09.004. Epub 2012 Oct 11.